Stem cell study uncovers molecular pathway for enamel regeneration
Tooth enamel is the hardest substance in the human body, yet once damaged, it cannot regenerate naturally. To…
DNA-guided CRISPR system targets RNA and expands Cas12 beyond gene editing
A DNA-guided CRISPR platform could make RNA detection and control more stable, scalable, and precise, opening new routes…
AI and CRISPR technologies drive proactive health monitoring
JMIR Publications today featured two new stories in its News and Perspectives section, highlighting a shift toward proactive,…
New CRISPR tool selectively cuts tumor DNA while sparing healthy cells
Apr 15 2026 Cancer cells excel at evading detection, but subtle chemical differences set them apart from healthy…
New polygenic risk scores improve prediction of metabolic disease outcomes
Type 2 diabetes (T2D) and obesity are metabolic conditions with many causes, including overlapping and distinct genetic features.…
New CRISPR technique boosts mitochondrial function to treat heart failure
After a heart attack, the heart struggles to recoup and maintain energy. One third of patients develop heart…
New diagnostic system leverages AI to help fight hospital-acquired infections
An AI tool developed by U of T Engineering professor Nicole Weckman (ISTEP, ChemE) can quickly diagnose infections…
AI‑Designed Anti‑CRISPRs Enable Rapid Cas13 Inhibition
Credit: Meletios Verras/Getty Images Last year’s landmark case of “Baby KJ”—the first patient to receive a personalized CRISPR‑based…
Engineering muscle stem cells for sustainable cultured meat production
The production of cultured meat depends on the isolation, expansion, and differentiation of animal stem cells into edible…
Epigenetic editing enables safer and more effective T cell therapies
Arc Institute, Gladstone Institutes, and University of California, San Francisco, scientists have developed an epigenetic editing platform that…
A Rogue Gene Explains Mysterious Cases of Diabetes and Epilepsy in Newborns
Credit: Wikimedia Commons When six infants around the world were diagnosed with an odd trio of symptoms (diabetes,…
After 1- and 6-Month Gains, Gene Editing Companies Await Q3 Results
As developers of gene editing therapies and other genetic medicines get set to report third quarter earnings in…